Skip to main content
Caplight Logo









CereCura Nanotherapeutics

CereCura Nanotherapeutics

Private
VancouverHealthcare & Life Scienceshttps://www.cerecura.com/

Last Round

Seed

Nov 14, 2025

Total Funding Raised

$1.81M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

CereCura Nanotherapeutics is a biotechnology company that develops lipid nanoparticle-based RNA therapeutics to treat neurological disorders by enabling the brain to synthesize its own therapeutic proteins.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

lipid nanoparticleLNPRNA therapeuticsblood-brain barrierneurological disordersdrug deliverynanomedicinebiotech startuppreclinical biotechgene therapyCNS drug deliverytherapeutic proteinbiotech R&Dnon-dilutive funding

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CereCura Nanotherapeutics Comparables

Compare CereCura Nanotherapeutics with similar companies based on industry and business-model similarity.

CereCura Nanotherapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
QurCan Therapeutics
86%
Aerska
81%
Gate2Brain
79%

CereCura Nanotherapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 14, 2025

Key People

Founding team and executive leadership

Louis-Philippe Bernier

Chief Executive Officer at CereCura Nanotherapeutics

Executive Team

CereCura Nanotherapeutics Investors

Notable investors and investment history

CereCura Nanotherapeutics investors
InvestorRounds
E-FundSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 29, 2026

    Monthly visitors increased 85% MoM.

  • Nov 14, 2025

    $1M round led by wutif-capital

CereCura Nanotherapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CereCura Nanotherapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CereCura Nanotherapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersVancouver
Employee Range9
Year Founded2022
Last FundingNov 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?